Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,581.00
(
1.15%
)
US TECH 100
23,598.40
(
1.36%
)
Dow Jones
46,208.47
(
1.38%
)
Brent Oil
96.79
(
-10.49%
)
Bitcoin
70,938.00
(
0.05%
)
News Focus
News Focus
Post# of 19309
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122807
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: gfp927z post# 1662

Thursday, 11/02/2006 11:43:12 PM

Thursday, November 02, 2006 11:43:12 PM

Post# of 19309
>Sepsis has always been a graveyard for pharma development. I wonder if reliance on this program is one of the reasons for GTCB's overall weakness?<

The thinking on how to treat sepsis with DIC has been undergone a radical shift in the past couple of years, and this is why Leo and GTC opted to pursue this indication. Please see the references in #msg-14363831. Regards, Dew

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Unleash the power of Level 2

Spot liquidity moves with access to US order books.

Sign Up